I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Featured trial
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.
ly573144
migraine in children
acute treatment
migraine
lasmiditan
- 0 views
- 19 Feb, 2024
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.
ly573144
preventive medication
headache
treatment regimen
migraine
- 0 views
- 19 Feb, 2024